Publications: All (49)

Gravdal K, Kirste KH, Grzelak K, Kirubakaran GT, Leissner P, Saliou A, Casèn C. Exploring the gut microbiota in patients with pre-diabetes and treatment naïve diabetes type 2 - a pilot study - PubMed (nih.gov). BMC Endocr Disord. 2023 Aug 21;23(1):179. doi: 10.1186/s12902-023-01432-0. PMID: 37605183; PMCID: PMC10440924.

Algera JP, Magnusson MK, Öhman L, Störsrud S, Simrén M, Törnblom H. Randomised controlled trial: effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome - PubMed (nih.gov). Aliment Pharmacol Ther. 2022 Sep 29. doi: 10.1111/apt.17239. Epub ahead of print. PMID: 36173041.

Telle-Hansen VH, Gaundal L, Bastani N, Rud I, Byfuglien MG, Gjøvaag T, Retterstøl K, Holven KB, Ulven SM, Myhrstad MCW. Replacing saturated fatty acids with polyunsaturated fatty acids increases the abundance of Lachnospiraceae and is associated with reduced total cholesterol levels-a randomized controlled trial in healthy individuals - PubMed (nih.gov). Lipids Health Dis. 2022 Sep 26;21(1):92. doi: 10.1186/s12944-022-01702-1. PMID: 36163070.

Gaundal L, Myhrstad MCW, Rud I, Gjøvaag T, Byfuglien MG, Retterstøl K, Holven KB, Ulven SM, Telle-Hansen VH. Gut microbiota is associated with dietary intake and metabolic markers in healthy individuals - PubMed (nih.gov) Food Nutr Res. 2022 Jun 23;66. doi: 10.29219/fnr.v66.8580. PMID: 35844956; PMCID: PMC9250133.

Kumar A, Gravdal K, Segal JP, Steed H, Brookes MJ, Al-Hassi HO. Variability in the Pre-Analytical Stages Influences Microbiome Laboratory Analyses - PubMed (nih.gov) Genes (Basel). 2022 Jun 15;13(6):1069. doi: 10.3390/genes13061069. PMID: 35741831; PMCID: PMC9223004.

El-Salhy M, Winkel R, Casen C, Hausken T, Gilja OH, Hatlebakk JG. Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation - PubMed (nih.gov) Gastroenterology. 2022 Jun 13:S0016-5085(22)00625-4. doi: 10.1053/j.gastro.2022.06.020. Epub ahead of print. PMID: 35709830.

Iribarren C, Nordlander S, Sundin J, Isaksson S, Savolainen O, Törnblom H, Magnusson MK, Simrén M, Öhman LFecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids - PubMed (nih.gov). Neurogastroenterol Motil. 2022 Apr 29:e14390. doi: 10.1111/nmo.14390. Epub ahead of print. PMID: 35485994.

El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms - PubMed (nih.gov). Scand J Gastroenterol. 2022 Apr 29:1-10. doi: 10.1080/00365521.2022.2064725. Epub ahead of print. PMID: 35486073.

El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG. Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation - PubMed (nih.gov). Neurogastroenterol Motil. 2022 Mar 18:e14353. doi: 10.1111/nmo.14353. Epub ahead of print. PMID: 35302268.

Rej A, Sanders DS, Shaw CC, Buckle R, Trott N, Agrawal A, Aziz I. Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet - PubMed (nih.gov). Clin Gastroenterol Hepatol. 2022 Feb 28:S1542-3565(22)00202-6. doi: 10.1016/j.cgh.2022.02.045. Epub ahead of print. PMID: 35240330.

Sagard J, Olofsson T, Mogard E, Marsal J, Andréasson K, Geijer M, Kristensen LE, Lindqvist E, Wallman JK. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis - PubMed (nih.gov). Arthritis Res Ther. 2022 Feb 12;24(1):42. doi: 10.1186/s13075-022-02733-w. PMID: 35151357; PMCID: PMC8840679.

Colomier E, Van Oudenhove L, Tack J, Böhn L, Bennet S, Nybacka S, Störsrud S, Öhman L, Törnblom H, Simrén M. Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome - PubMed (nih.gov). Nutrients. 2022 Jan 17;14(2):397. doi: 10.3390/nu14020397. PMID: 35057578; PMCID: PMC8780869.

Vasapolli R, Schulz C, Schweden M, Casèn C, Kirubakaran GT, Kirste KH, Macke L, Link A, Schütte K, Malfertheiner P. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID) - PubMed (nih.gov). Eur J Clin Invest. 2021 Aug 14:e13666. doi: 10.1111/eci.13666. Epub ahead of print. PMID: 34390492.

El-Salhy M, Kristoffersen AB, Valeur J, Casen C, Hatlebakk JG, Gilja OH, Hausken T. Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome - PubMed (nih.gov). Neurogastroenterol Motil. 2021 Jun 18:e14200. doi: 10.1111/nmo.14200. Epub ahead of print. PMID: 34145677.

Ahluwalia B, Iribarren C, Magnusson MK, Sundin J, Clevers E, Savolainen O, Ross AB, Törnblom H, Simrén M, Öhman LA Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome - PubMed (nih.gov). Cells. 2021 Jun 10;10(6):1459. doi: 10.3390/cells10061459. PMID: 34200772; PMCID: PMC8230381.

El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome - PubMed (nih.gov). World J Gastroenterol 2021; 27(18): 2219-2237 [DOI: 10.3748/wjg.v27.i18.2219]

Mazzawi T, El-Salhy M, Lied GA, Hausken T. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome - PubMed (nih.gov). Front Cell Infect Microbiol. 2021 May 12;11:524851. doi: 10.3389/fcimb.2021.524851. PMID: 34055657; PMCID: PMC8149964.

Öhman L, Lasson A, Strömbeck A, Isaksson S, Hesselmar M, Simrén M, Strid H, Magnusson MK. Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis - PubMed (nih.gov). Sci Rep. 2021 Apr 21;11(1):8641. doi: 10.1038/s41598-021-87973-7. PMID: 33883600; PMCID: PMC8060394.

Wei S, Bahl MI, Baunwall SMD, Hvas CL, Licht TR. Determining Gut Microbial Dysbiosis - Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances - PubMed (nih.gov). Appl Environ Microbiol. 2021 Mar 19:AEM.00395-21. doi: 10.1128/AEM.00395-21. Epub ahead of print. PMID: 33741632.

Bratlie M, Hagen IV, Helland A, Erchinger F, Midttun Ø, Ueland PM, Rosenlund G, Sveier H, Mellgren G, Hausken T, Gudbrandsen OA. Effects of high intake of cod or salmon on gut microbiota profile, faecal output and serum concentrations of lipids and bile acids in overweight adults: a randomised clinical trial - PubMed (nih.gov). Eur J Nutr. 2020 Oct 27.

Andréasson K, Neringer K, Wuttge DM, Henrohn D, Marsal J, Hesselstrand R. Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation-a prospective, observational study - PubMed (nih.gov). Arthritis Res Ther. 2020 Oct 6;22(1):230. doi: 10.1186/s13075-020-02323-8. PMID: 33023643; PMCID: PMC7539387.

Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Casén C, Moen AEF, Tannaes TM, Lindstrøm J, Detlie TE, Olbjørn C, Lindquist CM, Söderholm JD, Gomollón F, Kalla R, Satsangi J, Vatn MH, Jahnsen J, Halfvarson J, Ricanek P; Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character) - PubMed (nih.gov). Scand J Gastroenterol. 2020 Oct;55(10).

Berentsen B, Nagaraja BH, Teige EP, Lied GA, Lundervold AJ, Lundervold K, Steinsvik EK, Hillestad ER, Valeur J, Brønstad I, Gilja OH, Osnes B, Hatlebakk JG, Haász J, Labus J, Gupta A, Mayer EA, Benitez-Páez A, Sanz Y, Lundervold A, Hausken T. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome - PubMed (nih.gov). Medicine (Baltimore). 2020 Sep 11;99(37):e21950. doi: 10.1097/MD.0000000000021950. PMID: 32925728; PMCID: PMC7489588.

Aasbrenn M, Lydersen S, Farup PG. Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions: a prospective cohort study - PubMed (nih.gov). BMC Endocr Disord. 2020;20(1):108. Published 2020 Jul 22.

Ganda Mall JP, Fart F, Sabet JA, et al. Effects of Dietary Fibres on Acute Indomethacin-Induced Intestinal Hyperpermeability in the Elderly: A Randomised Placebo Controlled Parallel Clinical Trial - PubMed (nih.gov). Nutrients. 2020;12(7):E1954. Published 2020 Jun 30.

Iribarren C, Törnblom H, Aziz I, et al. Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double-blind, placebo-controlled study - PubMed (nih.gov) [published online ahead of print, 2020 Jun 14]. Neurogastroenterol Motil. 2020;e13920.

Strömbeck A, Lasson A, Strid H, et al. Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease - PubMed (nih.gov). BMC Gastroenterol. 2020;20(1):130. Published 2020 May 4.

Farup PG, Valeur J. Changes in Faecal Short-Chain Fatty Acids after Weight-Loss Interventions in Subjects with Morbid Obesity - PubMed (nih.gov). Nutrients. 2020;12(3):802. Published 2020 Mar 18.

Mazzawi T, Eikrem Ø, Lied GA, Hausken T. Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation - PubMed (nih.gov). Gastroenterol Res Pract. 2020;2020:3520686. Published 2020 Feb 4.

El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study - PubMed (nih.gov). Gut. 2020;69(5):859-867.

Klingberg E, Magnusson MK, Strid H, et al. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin - PubMed (nih.gov). Arthritis Res Ther. 2019;21(1):248. Published 2019 Nov 27.

Farup PG, Lydersen S, Valeur J. Are Nonnutritive Sweeteners Obesogenic? Associations between Diet, Faecal Microbiota, and Short-Chain Fatty Acids in Morbidly Obese Subjects - PubMed (nih.gov). J Obes. 2019; 2019:4608315. Published 2019 Oct 1.

El-Salhy M, Hausken T, Hatlebakk JGIncreasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS) - PubMed (nih.gov). Nutrients. 2019;11(6):1415. Published 2019 Jun 24.

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, et al. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome - PubMed (nih.gov). Clin Exp Gastroenterol. 2019;12:37-49. Published 2019 Jan 31.

Farup PG, Aasbrenn M, Valeur JSeparating "good" from "bad" faecal dysbiosis - evidence from two cross-sectional studies - PubMed (nih.gov). BMC Obes. 2018;5:30. Published 2018 Dec 3.

Mazzawi T, Lied GA, Sangnes DA, et al The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation - PubMed (nih.gov). PLoS One. 2018;13(11):e0194904. Published 2018 Nov 14.

Farup PG, Valeur J. Faecal Microbial Markers and Psychobiological Disorders in Subjects with Morbid Obesity. A Cross-Sectional Study - PubMed (nih.gov). Behav Sci (Basel). 2018;8(10):89. Published 2018 Sep 27.

Bennet SMP, Böhn L, Störsrud S, et al. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs - PubMed (nih.gov). Gut. 2018;67(5):872-881.

Valeur J, Småstuen MC, Knudsen T, Lied GA, Røseth AG. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome - PubMed (nih.gov). Dig Dis Sci. 2018;63(2):429-436.

Aasbrenn M, Valeur J, Farup PG. Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity - PubMed (nih.gov). Scand J Clin Lab Invest. 2018;78(1-2):109-113.

Mandl T, Marsal J, Olsson P, Ohlsson B, Andréasson K. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity - PubMed (nih.gov). Arthritis Res Ther. 2017;19(1):237. Published 2017 Oct 24.

Magnusson MK, Strid H, Isaksson S, Simrén M, Öhman L. The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis - PubMed (nih.gov). Inflamm Bowel Dis. 2017;23(6):956-966.

Hustoft TN, Hausken T, Ystad SO, et al. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome - PubMed (nih.gov). Neurogastroenterol Motil. 2017;29(4):10.1111/nmo.12969.

Andréasson K, Alrawi Z, Persson A, Jönsson G, Marsal J. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease - PubMed (nih.gov). Arthritis Res Ther. 2016;18(1):278. Published 2016 Nov 29.

Vebø HC, Karlsson MK, Avershina E, Finnby L, Rudi K. Bead-beating artefacts in the Bacteroidetes to Firmicutes ratio of the human stool metagenome - PubMed (nih.gov). J Microbiol Methods. 2016;129:78-80.

Magnusson MK, Strid H, Sapnara M, et al. Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition - PubMed (nih.gov). J Crohns Colitis. 2016;10(8):943-952.

Casén C, Vebø HC, Sekelja M, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD - PubMed (nih.gov). Aliment Pharmacol Ther. 2015;42(1):71-83.

Thorkildsen LT, Nwosu FC, Avershina E, et al. Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients - PubMed (nih.gov). Gastroenterol Res Pract. 2013;2013:636785.

Vebø HC, Sekelja M, Nestestog R, et al. Temporal development of the infant gut microbiota in immunoglobulin E-sensitized and nonsensitized children determined by the GA-map infant array - PubMed (nih.gov). Clin Vaccine Immunol. 2011;18(8):1326-1335.